Skip to main content
. 2021 Sep 20;6(5):100270. doi: 10.1016/j.esmoop.2021.100270

Figure 1.

Figure 1

Relative change from baseline in the target lesion size according to best overall response for evaluable patients in (A) cohort A and (B) cohort B. Cohort B includes one patient who was not included in the final efficacy analysis (this patient had high levels of microsatellite instability).